SFSIG
PGEN icon

San Francisco Sentry Investment Group’s Precigen PGEN Stock Holding History

San Francisco Sentry Investment Group’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-100
Closed -$2K – 845
2018
Q1 		$2K Hold
100
– – ﹤0.01% 862
2017
Q4 		$1K Hold
100
– – ﹤0.01% 886
2017
Q3 		$2K Hold
100
– – ﹤0.01% 857
2017
Q2 		$2K Buy
+100
New +$2.19K ﹤0.01% 700

Other funds holding PGEN

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

San Francisco Sentry Investment Group's PGEN Position: Q2 2018 in Review

San Francisco Sentry Investment Group sold out of Precigen (PGEN) in Q2 2018, closing a stake of 100 shares — an estimated $2K sold.

San Francisco Sentry Investment Group first reported a position in PGEN in Q2 2017 and held it in 4 quarters. The position peaked at $2K in Q1 2018. 166 funds tracked by Wall St. Rank hold PGEN as of Q2 2018.

  • San Francisco Sentry Investment Group reported no remaining Precigen position as of Q2 2018 after selling out during the quarter.
  • San Francisco Sentry Investment Group sold 100 Precigen shares in Q2 2018, an estimated $2K.
  • San Francisco Sentry Investment Group first reported a position in Precigen in Q2 2017 and held it in 4 quarters.
  • San Francisco Sentry Investment Group's Precigen position peaked at $2K in Q1 2018.
  • 166 funds tracked by Wall St. Rank held Precigen as of Q2 2018.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2018, filed 6 Aug 2018.